Industry Research Reports

Home > Reports > Chemical & Material > Global Milbemycin Oxime API Market Insights, Forecast to 2029

Global Milbemycin Oxime API Market Insights, Forecast to 2029

Industry: Chemical & Material

Published: 2023-07-31

Pages: 77 Pages

Report ld: 1616529

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Milbemycin is a new type of semi-synthetic macrolide anthelmintic. It is an oxime derivative of Milbemycin A3 and A4. The molecular weight of A3 oxime is 541.7, and the molecular weight of A4 oxime is 555.7. In terms of application, milbexime can be used alone or in combination with nitenpyram, lufenuron, spinosad, praziquantel, etc. to form a compound preparation, which can effectively prevent and control heartworms, hookworms, roundworms, whipworms, roundworms and other internal parasites, as well as hair follicles, scabies, lice, fleas and other external parasites. Milbexime acts as an agonist of the GABA (gamma-aminobutyric acid) neurotransmitter in nerve cells and also binds to glutamate-gated Cl– channels in invertebrate nerve and muscle cells. In both cases, it blocks the parasite's nerve signaling, eventually paralyzing the parasite, causing the muscles to lose their ability to contract, stop feeding, and cause the parasite to die.

Global Milbemycin Oxime API market is expected to reach to US$ 209.4 million in 2023, with a positive growth of %, compared with US$ 183.7 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Milbemycin Oxime API industry is evaluated to reach US$ 304 million in 2029. The CAGR will be 6.4% during 2023 to 2029.

Global 3 largest manufacturers of Milbemycin Oxime API are Livzon Pharmaceutical Group Inc, Zhejiang Hisun Pharmaceutical Co., Ltd and Hubei Honch Pharmaceutical Co.,Ltd, which make up over 40%. Among them, Livzon Pharmaceutical Group Inc is the leader with about 22% market share. North America is the largest market, with a share about 48%, followed by Europe and China, with the share about 46% and 2%. In terms of product type, Purity Greater than 98% occupy the largest share of the total market, about 85%. And in terms of product Application, the largest application is Dog, followed by Cat.

Report Covers:
This report presents an overview of global Milbemycin Oxime API market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Milbemycin Oxime API market with multiple angles. Items like regional production, sales, revenue from 2018 to 2029 and manufacturers’ capacity, sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted. 
Manufacturers, Type, Application and Regions Listed in the Report:

Report Metric
Details
Report Title
Global Milbemycin Oxime API Market Insights, Forecast to 2029
Global Milbemycin Oxime API Companies Covered
Livzon Pharmaceutical Group Inc, Zhejiang Hisun Pharmaceutical Co., Ltd, Hubei Honch Pharmaceutical Co.,Ltd, JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD
Global Milbemycin Oxime API Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Product definition, type and application introduction
Chapter 2: Regional production volume analysis from 2018 to 2029
Chapter 3: Regional revenue and sales volume analysis from 2018 to 2029
Chapter 4: Manufacturers’ sales, revenue and price analysis, including manufacturers’ Milbemycin Oxime API plant distribution, commercial date of Milbemycin Oxime API, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 5: Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 6: Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 7: Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 8: Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 9: Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 10: Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 11: Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 12: Manufacturers’ outline, covering company’s basic information, major business, Milbemycin Oxime API introduction, etc. Milbemycin Oxime API Capacity, Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 13: Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 14: Market opportunities and challenges analysis
Chapter 15: QYResearch’s Conclusions of Milbemycin Oxime API
Chapter 16: Methodology and Data Sources adopted by QYResearch

Table of Contents

 1 Study Coverage
    1.1 Milbemycin Oxime API Product Introduction
    1.2 Market by Type
        1.2.1 Global Milbemycin Oxime API Market Size by Type, 2018 VS 2022 VS 2029
        1.2.2 98% Purity
        1.2.3 Purity Greater than 98%
    1.3 Market by Application
        1.3.1 Global Milbemycin Oxime API Market Size by Application, 2018 VS 2022 VS 2029
        1.3.2 Dog
        1.3.3 Cat
        1.3.4 Other
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Global Milbemycin Oxime API Production
    2.1 Global Milbemycin Oxime API Production Capacity (2018-2029)
    2.2 Global Milbemycin Oxime API Production by Region: 2018 VS 2022 VS 2029
    2.3 Global Milbemycin Oxime API Production by Region
        2.3.1 Global Milbemycin Oxime API Historic Production by Region (2018-2023)
        2.3.2 Global Milbemycin Oxime API Forecasted Production by Region (2024-2029)
        2.3.3 Global Milbemycin Oxime API Production Market Share by Region (2018-2029)
    2.4 China

 3 Executive Summary
    3.1 Global Milbemycin Oxime API Revenue Estimates and Forecasts 2018-2029
    3.2 Global Milbemycin Oxime API Revenue by Region
        3.2.1 Global Milbemycin Oxime API Revenue by Region: 2018 VS 2022 VS 2029
        3.2.2 Global Milbemycin Oxime API Revenue by Region (2018-2023)
        3.2.3 Global Milbemycin Oxime API Revenue by Region (2024-2029)
        3.2.4 Global Milbemycin Oxime API Revenue Market Share by Region (2018-2029)
    3.3 Global Milbemycin Oxime API Sales Estimates and Forecasts 2018-2029
    3.4 Global Milbemycin Oxime API Sales by Region
        3.4.1 Global Milbemycin Oxime API Sales by Region: 2018 VS 2022 VS 2029
        3.4.2 Global Milbemycin Oxime API Sales by Region (2018-2023)
        3.4.3 Global Milbemycin Oxime API Sales by Region (2024-2029)
        3.4.4 Global Milbemycin Oxime API Sales Market Share by Region (2018-2029)
    3.5 US & Canada
    3.6 Europe
    3.7 China
    3.8 Asia (excluding China)
    3.9 Middle East, Africa and Latin America

 4 Competition by Manufactures
    4.1 Global Milbemycin Oxime API Sales by Manufacturers
        4.1.1 Global Milbemycin Oxime API Sales by Manufacturers (2018-2023)
        4.1.2 Global Milbemycin Oxime API Sales Market Share by Manufacturers (2018-2023)
        4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Milbemycin Oxime API in 2022
    4.2 Global Milbemycin Oxime API Revenue by Manufacturers
        4.2.1 Global Milbemycin Oxime API Revenue by Manufacturers (2018-2023)
        4.2.2 Global Milbemycin Oxime API Revenue Market Share by Manufacturers (2018-2023)
        4.2.3 Global Top 10 and Top 5 Companies by Milbemycin Oxime API Revenue in 2022
    4.3 Global Milbemycin Oxime API Sales Price by Manufacturers
    4.4 Global Key Players of Milbemycin Oxime API, Industry Ranking, 2021 VS 2022 VS 2023
    4.5 Analysis of Competitive Landscape
        4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        4.5.2 Global Milbemycin Oxime API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.6 Global Key Manufacturers of Milbemycin Oxime API, Manufacturing Base Distribution and Headquarters
    4.7 Global Key Manufacturers of Milbemycin Oxime API, Product Offered and Application
    4.8 Global Key Manufacturers of Milbemycin Oxime API, Date of Enter into This Industry
    4.9 Mergers & Acquisitions, Expansion Plans

 5 Market Size by Type
    5.1 Global Milbemycin Oxime API Sales by Type
        5.1.1 Global Milbemycin Oxime API Historical Sales by Type (2018-2023)
        5.1.2 Global Milbemycin Oxime API Forecasted Sales by Type (2024-2029)
        5.1.3 Global Milbemycin Oxime API Sales Market Share by Type (2018-2029)
    5.2 Global Milbemycin Oxime API Revenue by Type
        5.2.1 Global Milbemycin Oxime API Historical Revenue by Type (2018-2023)
        5.2.2 Global Milbemycin Oxime API Forecasted Revenue by Type (2024-2029)
        5.2.3 Global Milbemycin Oxime API Revenue Market Share by Type (2018-2029)
    5.3 Global Milbemycin Oxime API Price by Type
        5.3.1 Global Milbemycin Oxime API Price by Type (2018-2023)
        5.3.2 Global Milbemycin Oxime API Price Forecast by Type (2024-2029)

 6 Market Size by Application
    6.1 Global Milbemycin Oxime API Sales by Application
        6.1.1 Global Milbemycin Oxime API Historical Sales by Application (2018-2023)
        6.1.2 Global Milbemycin Oxime API Forecasted Sales by Application (2024-2029)
        6.1.3 Global Milbemycin Oxime API Sales Market Share by Application (2018-2029)
    6.2 Global Milbemycin Oxime API Revenue by Application
        6.2.1 Global Milbemycin Oxime API Historical Revenue by Application (2018-2023)
        6.2.2 Global Milbemycin Oxime API Forecasted Revenue by Application (2024-2029)
        6.2.3 Global Milbemycin Oxime API Revenue Market Share by Application (2018-2029)
    6.3 Global Milbemycin Oxime API Price by Application
        6.3.1 Global Milbemycin Oxime API Price by Application (2018-2023)
        6.3.2 Global Milbemycin Oxime API Price Forecast by Application (2024-2029)

 7 US & Canada
    7.1 US & Canada Milbemycin Oxime API Market Size by Type
        7.1.1 US & Canada Milbemycin Oxime API Sales by Type (2018-2029)
        7.1.2 US & Canada Milbemycin Oxime API Revenue by Type (2018-2029)
    7.2 US & Canada Milbemycin Oxime API Market Size by Application
        7.2.1 US & Canada Milbemycin Oxime API Sales by Application (2018-2029)
        7.2.2 US & Canada Milbemycin Oxime API Revenue by Application (2018-2029)
    7.3 US & Canada Milbemycin Oxime API Sales by Country
        7.3.1 US & Canada Milbemycin Oxime API Revenue by Country: 2018 VS 2022 VS 2029
        7.3.2 US & Canada Milbemycin Oxime API Sales by Country (2018-2029)
        7.3.3 US & Canada Milbemycin Oxime API Revenue by Country (2018-2029)
        7.3.4 United States
        7.3.5 Canada

 8 Europe
    8.1 Europe Milbemycin Oxime API Market Size by Type
        8.1.1 Europe Milbemycin Oxime API Sales by Type (2018-2029)
        8.1.2 Europe Milbemycin Oxime API Revenue by Type (2018-2029)
    8.2 Europe Milbemycin Oxime API Market Size by Application
        8.2.1 Europe Milbemycin Oxime API Sales by Application (2018-2029)
        8.2.2 Europe Milbemycin Oxime API Revenue by Application (2018-2029)
    8.3 Europe Milbemycin Oxime API Sales by Country
        8.3.1 Europe Milbemycin Oxime API Revenue by Country: 2018 VS 2022 VS 2029
        8.3.2 Europe Milbemycin Oxime API Sales by Country (2018-2029)
        8.3.3 Europe Milbemycin Oxime API Revenue by Country (2018-2029)
        8.3.4 Germany
        8.3.5 France
        8.3.6 U.K.
        8.3.7 Italy
        8.3.8 Russia

 9 China
    9.1 China Milbemycin Oxime API Market Size by Type
        9.1.1 China Milbemycin Oxime API Sales by Type (2018-2029)
        9.1.2 China Milbemycin Oxime API Revenue by Type (2018-2029)
    9.2 China Milbemycin Oxime API Market Size by Application
        9.2.1 China Milbemycin Oxime API Sales by Application (2018-2029)
        9.2.2 China Milbemycin Oxime API Revenue by Application (2018-2029)

 10 Asia (excluding China)
    10.1 Asia Milbemycin Oxime API Market Size by Type
        10.1.1 Asia Milbemycin Oxime API Sales by Type (2018-2029)
        10.1.2 Asia Milbemycin Oxime API Revenue by Type (2018-2029)
    10.2 Asia Milbemycin Oxime API Market Size by Application
        10.2.1 Asia Milbemycin Oxime API Sales by Application (2018-2029)
        10.2.2 Asia Milbemycin Oxime API Revenue by Application (2018-2029)
    10.3 Asia Milbemycin Oxime API Sales by Region
        10.3.1 Asia Milbemycin Oxime API Revenue by Region: 2018 VS 2022 VS 2029
        10.3.2 Asia Milbemycin Oxime API Revenue by Region (2018-2029)
        10.3.3 Asia Milbemycin Oxime API Sales by Region (2018-2029)
        10.3.4 Japan
        10.3.5 South Korea
        10.3.6 China Taiwan
        10.3.7 Southeast Asia
        10.3.8 India

 11 Middle East, Africa and Latin America
    11.1 Middle East, Africa and Latin America Milbemycin Oxime API Market Size by Type
        11.1.1 Middle East, Africa and Latin America Milbemycin Oxime API Sales by Type (2018-2029)
        11.1.2 Middle East, Africa and Latin America Milbemycin Oxime API Revenue by Type (2018-2029)
    11.2 Middle East, Africa and Latin America Milbemycin Oxime API Market Size by Application
        11.2.1 Middle East, Africa and Latin America Milbemycin Oxime API Sales by Application (2018-2029)
        11.2.2 Middle East, Africa and Latin America Milbemycin Oxime API Revenue by Application (2018-2029)
    11.3 Middle East, Africa and Latin America Milbemycin Oxime API Sales by Country
        11.3.1 Middle East, Africa and Latin America Milbemycin Oxime API Revenue by Country: 2018 VS 2022 VS 2029
        11.3.2 Middle East, Africa and Latin America Milbemycin Oxime API Revenue by Country (2018-2029)
        11.3.3 Middle East, Africa and Latin America Milbemycin Oxime API Sales by Country (2018-2029)
        11.3.4 Brazil
        11.3.5 Mexico
        11.3.6 Turkey
        11.3.7 Israel
        11.3.8 GCC Countries

 12 Corporate Profiles
    12.1 Livzon Pharmaceutical Group Inc
        12.1.1 Livzon Pharmaceutical Group Inc Company Information
        12.1.2 Livzon Pharmaceutical Group Inc Overview
        12.1.3 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
        12.1.4 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Product Model Numbers, Pictures, Descriptions and Specifications
        12.1.5 Livzon Pharmaceutical Group Inc Recent Developments
    12.2 Zhejiang Hisun Pharmaceutical Co., Ltd
        12.2.1 Zhejiang Hisun Pharmaceutical Co., Ltd Company Information
        12.2.2 Zhejiang Hisun Pharmaceutical Co., Ltd Overview
        12.2.3 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
        12.2.4 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Product Model Numbers, Pictures, Descriptions and Specifications
        12.2.5 Zhejiang Hisun Pharmaceutical Co., Ltd Recent Developments
    12.3 Hubei Honch Pharmaceutical Co.,Ltd
        12.3.1 Hubei Honch Pharmaceutical Co.,Ltd Company Information
        12.3.2 Hubei Honch Pharmaceutical Co.,Ltd Overview
        12.3.3 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
        12.3.4 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Product Model Numbers, Pictures, Descriptions and Specifications
        12.3.5 Hubei Honch Pharmaceutical Co.,Ltd Recent Developments
    12.4 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD
        12.4.1 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Company Information
        12.4.2 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Overview
        12.4.3 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
        12.4.4 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Product Model Numbers, Pictures, Descriptions and Specifications
        12.4.5 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Recent Developments

 13 Industry Chain and Sales Channels Analysis
    13.1 Milbemycin Oxime API Industry Chain Analysis
    13.2 Milbemycin Oxime API Key Raw Materials
        13.2.1 Key Raw Materials
        13.2.2 Raw Materials Key Suppliers
    13.3 Milbemycin Oxime API Production Mode & Process
    13.4 Milbemycin Oxime API Sales and Marketing
        13.4.1 Milbemycin Oxime API Sales Channels
        13.4.2 Milbemycin Oxime API Distributors
    13.5 Milbemycin Oxime API Customers

 14 Milbemycin Oxime API Market Dynamics
    14.1 Milbemycin Oxime API Industry Trends
    14.2 Milbemycin Oxime API Market Drivers
    14.3 Milbemycin Oxime API Market Challenges
    14.4 Milbemycin Oxime API Market Restraints

 15 Key Finding in The Global Milbemycin Oxime API Study

 16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Milbemycin Oxime API Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Table 2. Major Manufacturers of 98% Purity
    Table 3. Major Manufacturers of Purity Greater than 98%
    Table 4. Global Milbemycin Oxime API Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Table 5. Global Milbemycin Oxime API Production by Region: 2018 VS 2022 VS 2029 (KG)
    Table 6. Global Milbemycin Oxime API Production by Region (2018-2023) & (KG)
    Table 7. Global Milbemycin Oxime API Production by Region (2024-2029) & (KG)
    Table 8. Global Milbemycin Oxime API Production Market Share by Region (2018-2023)
    Table 9. Global Milbemycin Oxime API Production Market Share by Region (2024-2029)
    Table 10. Global Milbemycin Oxime API Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 11. Global Milbemycin Oxime API Revenue by Region (2018-2023) & (US$ Million)
    Table 12. Global Milbemycin Oxime API Revenue by Region (2024-2029) & (US$ Million)
    Table 13. Global Milbemycin Oxime API Revenue Market Share by Region (2018-2023)
    Table 14. Global Milbemycin Oxime API Revenue Market Share by Region (2024-2029)
    Table 15. Global Milbemycin Oxime API Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 16. Global Milbemycin Oxime API Sales by Region (2018-2023) & (KG)
    Table 17. Global Milbemycin Oxime API Sales by Region (2024-2029) & (KG)
    Table 18. Global Milbemycin Oxime API Sales Market Share by Region (2018-2023)
    Table 19. Global Milbemycin Oxime API Sales Market Share by Region (2024-2029)
    Table 20. Global Milbemycin Oxime API Sales by Manufacturers (2018-2023) & (KG)
    Table 21. Global Milbemycin Oxime API Sales Share by Manufacturers (2018-2023)
    Table 22. Global Milbemycin Oxime API Revenue by Manufacturers (2018-2023) & (US$ Million)
    Table 23. Global Milbemycin Oxime API Revenue Share by Manufacturers (2018-2023)
    Table 24. Milbemycin Oxime API Price by Manufacturers 2018-2023 (US$/KG)
    Table 25. Global Key Players of Milbemycin Oxime API, Industry Ranking, 2021 VS 2022 VS 2023
    Table 26. Global Milbemycin Oxime API Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 27. Global Milbemycin Oxime API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Milbemycin Oxime API as of 2022)
    Table 28. Global Key Manufacturers of Milbemycin Oxime API, Manufacturing Base Distribution and Headquarters
    Table 29. Global Key Manufacturers of Milbemycin Oxime API, Product Offered and Application
    Table 30. Global Key Manufacturers of Milbemycin Oxime API, Date of Enter into This Industry
    Table 31. Mergers & Acquisitions, Expansion Plans
    Table 32. Global Milbemycin Oxime API Sales by Type (2018-2023) & (KG)
    Table 33. Global Milbemycin Oxime API Sales by Type (2024-2029) & (KG)
    Table 34. Global Milbemycin Oxime API Sales Share by Type (2018-2023)
    Table 35. Global Milbemycin Oxime API Sales Share by Type (2024-2029)
    Table 36. Global Milbemycin Oxime API Revenue by Type (2018-2023) & (US$ Million)
    Table 37. Global Milbemycin Oxime API Revenue by Type (2024-2029) & (US$ Million)
    Table 38. Global Milbemycin Oxime API Revenue Share by Type (2018-2023)
    Table 39. Global Milbemycin Oxime API Revenue Share by Type (2024-2029)
    Table 40. Milbemycin Oxime API Price by Type (2018-2023) & (US$/KG)
    Table 41. Global Milbemycin Oxime API Price Forecast by Type (2024-2029) & (US$/KG)
    Table 42. Global Milbemycin Oxime API Sales by Application (2018-2023) & (KG)
    Table 43. Global Milbemycin Oxime API Sales by Application (2024-2029) & (KG)
    Table 44. Global Milbemycin Oxime API Sales Share by Application (2018-2023)
    Table 45. Global Milbemycin Oxime API Sales Share by Application (2024-2029)
    Table 46. Global Milbemycin Oxime API Revenue by Application (2018-2023) & (US$ Million)
    Table 47. Global Milbemycin Oxime API Revenue by Application (2024-2029) & (US$ Million)
    Table 48. Global Milbemycin Oxime API Revenue Share by Application (2018-2023)
    Table 49. Global Milbemycin Oxime API Revenue Share by Application (2024-2029)
    Table 50. Milbemycin Oxime API Price by Application (2018-2023) & (US$/KG)
    Table 51. Global Milbemycin Oxime API Price Forecast by Application (2024-2029) & (US$/KG)
    Table 52. US & Canada Milbemycin Oxime API Sales by Type (2018-2023) & (KG)
    Table 53. US & Canada Milbemycin Oxime API Sales by Type (2024-2029) & (KG)
    Table 54. US & Canada Milbemycin Oxime API Revenue by Type (2018-2023) & (US$ Million)
    Table 55. US & Canada Milbemycin Oxime API Revenue by Type (2024-2029) & (US$ Million)
    Table 56. US & Canada Milbemycin Oxime API Sales by Application (2018-2023) & (KG)
    Table 57. US & Canada Milbemycin Oxime API Sales by Application (2024-2029) & (KG)
    Table 58. US & Canada Milbemycin Oxime API Revenue by Application (2018-2023) & (US$ Million)
    Table 59. US & Canada Milbemycin Oxime API Revenue by Application (2024-2029) & (US$ Million)
    Table 60. US & Canada Milbemycin Oxime API Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 61. US & Canada Milbemycin Oxime API Revenue by Country (2018-2023) & (US$ Million)
    Table 62. US & Canada Milbemycin Oxime API Revenue by Country (2024-2029) & (US$ Million)
    Table 63. US & Canada Milbemycin Oxime API Sales by Country (2018-2023) & (KG)
    Table 64. US & Canada Milbemycin Oxime API Sales by Country (2024-2029) & (KG)
    Table 65. Europe Milbemycin Oxime API Sales by Type (2018-2023) & (KG)
    Table 66. Europe Milbemycin Oxime API Sales by Type (2024-2029) & (KG)
    Table 67. Europe Milbemycin Oxime API Revenue by Type (2018-2023) & (US$ Million)
    Table 68. Europe Milbemycin Oxime API Revenue by Type (2024-2029) & (US$ Million)
    Table 69. Europe Milbemycin Oxime API Sales by Application (2018-2023) & (KG)
    Table 70. Europe Milbemycin Oxime API Sales by Application (2024-2029) & (KG)
    Table 71. Europe Milbemycin Oxime API Revenue by Application (2018-2023) & (US$ Million)
    Table 72. Europe Milbemycin Oxime API Revenue by Application (2024-2029) & (US$ Million)
    Table 73. Europe Milbemycin Oxime API Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 74. Europe Milbemycin Oxime API Revenue by Country (2018-2023) & (US$ Million)
    Table 75. Europe Milbemycin Oxime API Revenue by Country (2024-2029) & (US$ Million)
    Table 76. Europe Milbemycin Oxime API Sales by Country (2018-2023) & (KG)
    Table 77. Europe Milbemycin Oxime API Sales by Country (2024-2029) & (KG)
    Table 78. China Milbemycin Oxime API Sales by Type (2018-2023) & (KG)
    Table 79. China Milbemycin Oxime API Sales by Type (2024-2029) & (KG)
    Table 80. China Milbemycin Oxime API Revenue by Type (2018-2023) & (US$ Million)
    Table 81. China Milbemycin Oxime API Revenue by Type (2024-2029) & (US$ Million)
    Table 82. China Milbemycin Oxime API Sales by Application (2018-2023) & (KG)
    Table 83. China Milbemycin Oxime API Sales by Application (2024-2029) & (KG)
    Table 84. China Milbemycin Oxime API Revenue by Application (2018-2023) & (US$ Million)
    Table 85. China Milbemycin Oxime API Revenue by Application (2024-2029) & (US$ Million)
    Table 86. Asia Milbemycin Oxime API Sales by Type (2018-2023) & (KG)
    Table 87. Asia Milbemycin Oxime API Sales by Type (2024-2029) & (KG)
    Table 88. Asia Milbemycin Oxime API Revenue by Type (2018-2023) & (US$ Million)
    Table 89. Asia Milbemycin Oxime API Revenue by Type (2024-2029) & (US$ Million)
    Table 90. Asia Milbemycin Oxime API Sales by Application (2018-2023) & (KG)
    Table 91. Asia Milbemycin Oxime API Sales by Application (2024-2029) & (KG)
    Table 92. Asia Milbemycin Oxime API Revenue by Application (2018-2023) & (US$ Million)
    Table 93. Asia Milbemycin Oxime API Revenue by Application (2024-2029) & (US$ Million)
    Table 94. Asia Milbemycin Oxime API Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 95. Asia Milbemycin Oxime API Revenue by Region (2018-2023) & (US$ Million)
    Table 96. Asia Milbemycin Oxime API Revenue by Region (2024-2029) & (US$ Million)
    Table 97. Asia Milbemycin Oxime API Sales by Region (2018-2023) & (KG)
    Table 98. Asia Milbemycin Oxime API Sales by Region (2024-2029) & (KG)
    Table 99. Middle East, Africa and Latin America Milbemycin Oxime API Sales by Type (2018-2023) & (KG)
    Table 100. Middle East, Africa and Latin America Milbemycin Oxime API Sales by Type (2024-2029) & (KG)
    Table 101. Middle East, Africa and Latin America Milbemycin Oxime API Revenue by Type (2018-2023) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Milbemycin Oxime API Revenue by Type (2024-2029) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Milbemycin Oxime API Sales by Application (2018-2023) & (KG)
    Table 104. Middle East, Africa and Latin America Milbemycin Oxime API Sales by Application (2024-2029) & (KG)
    Table 105. Middle East, Africa and Latin America Milbemycin Oxime API Revenue by Application (2018-2023) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Milbemycin Oxime API Revenue by Application (2024-2029) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Milbemycin Oxime API Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 108. Middle East, Africa and Latin America Milbemycin Oxime API Revenue by Country (2018-2023) & (US$ Million)
    Table 109. Middle East, Africa and Latin America Milbemycin Oxime API Revenue by Country (2024-2029) & (US$ Million)
    Table 110. Middle East, Africa and Latin America Milbemycin Oxime API Sales by Country (2018-2023) & (KG)
    Table 111. Middle East, Africa and Latin America Milbemycin Oxime API Sales by Country (2024-2029) & (KG)
    Table 112. Livzon Pharmaceutical Group Inc Company Information
    Table 113. Livzon Pharmaceutical Group Inc Description and Major Businesses
    Table 114. Livzon Pharmaceutical Group Inc Milbemycin Oxime API Capacity Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2018-2023)
    Table 115. Livzon Pharmaceutical Group Inc Milbemycin Oxime API Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Livzon Pharmaceutical Group Inc Recent Development
    Table 117. Zhejiang Hisun Pharmaceutical Co., Ltd Company Information
    Table 118. Zhejiang Hisun Pharmaceutical Co., Ltd Description and Major Businesses
    Table 119. Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Capacity Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2018-2023)
    Table 120. Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Zhejiang Hisun Pharmaceutical Co., Ltd Recent Development
    Table 122. Hubei Honch Pharmaceutical Co.,Ltd Company Information
    Table 123. Hubei Honch Pharmaceutical Co.,Ltd Description and Major Businesses
    Table 124. Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Capacity Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2018-2023)
    Table 125. Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Hubei Honch Pharmaceutical Co.,Ltd Recent Development
    Table 127. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Company Information
    Table 128. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Description and Major Businesses
    Table 129. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Capacity Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2018-2023)
    Table 130. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Recent Development
    Table 132. Key Raw Materials Lists
    Table 133. Raw Materials Key Suppliers Lists
    Table 134. Milbemycin Oxime API Distributors List
    Table 135. Milbemycin Oxime API Customers List
    Table 136. Milbemycin Oxime API Market Trends
    Table 137. Milbemycin Oxime API Market Drivers
    Table 138. Milbemycin Oxime API Market Challenges
    Table 139. Milbemycin Oxime API Market Restraints
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
List of Figures
    Figure 1. Milbemycin Oxime API Product Picture
    Figure 2. Global Milbemycin Oxime API Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Milbemycin Oxime API Market Share by Type in 2022 & 2029
    Figure 4. 98% Purity Product Picture
    Figure 5. Purity Greater than 98% Product Picture
    Figure 6. Global Milbemycin Oxime API Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 7. Global Milbemycin Oxime API Market Share by Application in 2022 & 2029
    Figure 8. Dog
    Figure 9. Cat
    Figure 10. Other
    Figure 11. Milbemycin Oxime API Report Years Considered
    Figure 12. Global Milbemycin Oxime API Capacity, Production and Utilization (2018-2029) & (KG)
    Figure 13. Global Milbemycin Oxime API Production Market Share by Region in Percentage: 2022 Versus 2029
    Figure 14. Global Milbemycin Oxime API Production Market Share by Region (2018-2029)
    Figure 15. Milbemycin Oxime API Production Growth Rate in China (2018-2029) & (KG)
    Figure 16. Global Milbemycin Oxime API Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 17. Global Milbemycin Oxime API Revenue 2018-2029 (US$ Million)
    Figure 18. Global Milbemycin Oxime API Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Figure 19. Global Milbemycin Oxime API Revenue Market Share by Region in Percentage: 2022 Versus 2029
    Figure 20. Global Milbemycin Oxime API Revenue Market Share by Region (2018-2029)
    Figure 21. Global Milbemycin Oxime API Sales 2018-2029 ((KG)
    Figure 22. Global Milbemycin Oxime API Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (KG)
    Figure 23. Global Milbemycin Oxime API Sales Market Share by Region (2018-2029)
    Figure 24. US & Canada Milbemycin Oxime API Sales YoY (2018-2029) & (KG)
    Figure 25. US & Canada Milbemycin Oxime API Revenue YoY (2018-2029) & (US$ Million)
    Figure 26. Europe Milbemycin Oxime API Sales YoY (2018-2029) & (KG)
    Figure 27. Europe Milbemycin Oxime API Revenue YoY (2018-2029) & (US$ Million)
    Figure 28. China Milbemycin Oxime API Sales YoY (2018-2029) & (KG)
    Figure 29. China Milbemycin Oxime API Revenue YoY (2018-2029) & (US$ Million)
    Figure 30. Asia (excluding China) Milbemycin Oxime API Sales YoY (2018-2029) & (KG)
    Figure 31. Asia (excluding China) Milbemycin Oxime API Revenue YoY (2018-2029) & (US$ Million)
    Figure 32. Middle East, Africa and Latin America Milbemycin Oxime API Sales YoY (2018-2029) & (KG)
    Figure 33. Middle East, Africa and Latin America Milbemycin Oxime API Revenue YoY (2018-2029) & (US$ Million)
    Figure 34. The Milbemycin Oxime API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
    Figure 35. The Top 5 and 10 Largest Manufacturers of Milbemycin Oxime API in the World: Market Share by Milbemycin Oxime API Revenue in 2022
    Figure 36. Global Milbemycin Oxime API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 37. Global Milbemycin Oxime API Sales Market Share by Type (2018-2029)
    Figure 38. Global Milbemycin Oxime API Revenue Market Share by Type (2018-2029)
    Figure 39. Global Milbemycin Oxime API Sales Market Share by Application (2018-2029)
    Figure 40. Global Milbemycin Oxime API Revenue Market Share by Application (2018-2029)
    Figure 41. US & Canada Milbemycin Oxime API Sales Market Share by Type (2018-2029)
    Figure 42. US & Canada Milbemycin Oxime API Revenue Market Share by Type (2018-2029)
    Figure 43. US & Canada Milbemycin Oxime API Sales Market Share by Application (2018-2029)
    Figure 44. US & Canada Milbemycin Oxime API Revenue Market Share by Application (2018-2029)
    Figure 45. US & Canada Milbemycin Oxime API Revenue Share by Country (2018-2029)
    Figure 46. US & Canada Milbemycin Oxime API Sales Share by Country (2018-2029)
    Figure 47. U.S. Milbemycin Oxime API Revenue (2018-2029) & (US$ Million)
    Figure 48. Canada Milbemycin Oxime API Revenue (2018-2029) & (US$ Million)
    Figure 49. Europe Milbemycin Oxime API Sales Market Share by Type (2018-2029)
    Figure 50. Europe Milbemycin Oxime API Revenue Market Share by Type (2018-2029)
    Figure 51. Europe Milbemycin Oxime API Sales Market Share by Application (2018-2029)
    Figure 52. Europe Milbemycin Oxime API Revenue Market Share by Application (2018-2029)
    Figure 53. Europe Milbemycin Oxime API Revenue Share by Country (2018-2029)
    Figure 54. Europe Milbemycin Oxime API Sales Share by Country (2018-2029)
    Figure 55. Germany Milbemycin Oxime API Revenue (2018-2029) & (US$ Million)
    Figure 56. France Milbemycin Oxime API Revenue (2018-2029) & (US$ Million)
    Figure 57. U.K. Milbemycin Oxime API Revenue (2018-2029) & (US$ Million)
    Figure 58. Italy Milbemycin Oxime API Revenue (2018-2029) & (US$ Million)
    Figure 59. Russia Milbemycin Oxime API Revenue (2018-2029) & (US$ Million)
    Figure 60. China Milbemycin Oxime API Sales Market Share by Type (2018-2029)
    Figure 61. China Milbemycin Oxime API Revenue Market Share by Type (2018-2029)
    Figure 62. China Milbemycin Oxime API Sales Market Share by Application (2018-2029)
    Figure 63. China Milbemycin Oxime API Revenue Market Share by Application (2018-2029)
    Figure 64. Asia Milbemycin Oxime API Sales Market Share by Type (2018-2029)
    Figure 65. Asia Milbemycin Oxime API Revenue Market Share by Type (2018-2029)
    Figure 66. Asia Milbemycin Oxime API Sales Market Share by Application (2018-2029)
    Figure 67. Asia Milbemycin Oxime API Revenue Market Share by Application (2018-2029)
    Figure 68. Asia Milbemycin Oxime API Revenue Share by Region (2018-2029)
    Figure 69. Asia Milbemycin Oxime API Sales Share by Region (2018-2029)
    Figure 70. Japan Milbemycin Oxime API Revenue (2018-2029) & (US$ Million)
    Figure 71. South Korea Milbemycin Oxime API Revenue (2018-2029) & (US$ Million)
    Figure 72. China Taiwan Milbemycin Oxime API Revenue (2018-2029) & (US$ Million)
    Figure 73. Southeast Asia Milbemycin Oxime API Revenue (2018-2029) & (US$ Million)
    Figure 74. India Milbemycin Oxime API Revenue (2018-2029) & (US$ Million)
    Figure 75. Middle East, Africa and Latin America Milbemycin Oxime API Sales Market Share by Type (2018-2029)
    Figure 76. Middle East, Africa and Latin America Milbemycin Oxime API Revenue Market Share by Type (2018-2029)
    Figure 77. Middle East, Africa and Latin America Milbemycin Oxime API Sales Market Share by Application (2018-2029)
    Figure 78. Middle East, Africa and Latin America Milbemycin Oxime API Revenue Market Share by Application (2018-2029)
    Figure 79. Middle East, Africa and Latin America Milbemycin Oxime API Revenue Share by Country (2018-2029)
    Figure 80. Middle East, Africa and Latin America Milbemycin Oxime API Sales Share by Country (2018-2029)
    Figure 81. Brazil Milbemycin Oxime API Revenue (2018-2029) & (US$ Million)
    Figure 82. Mexico Milbemycin Oxime API Revenue (2018-2029) & (US$ Million)
    Figure 83. Turkey Milbemycin Oxime API Revenue (2018-2029) & (US$ Million)
    Figure 84. Israel Milbemycin Oxime API Revenue (2018-2029) & (US$ Million)
    Figure 85. GCC Countries Milbemycin Oxime API Revenue (2018-2029) & (US$ Million)
    Figure 86. Milbemycin Oxime API Value Chain
    Figure 87. Milbemycin Oxime API Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed

Description

Milbemycin is a new type of semi-synthetic macrolide anthelmintic. It is an oxime derivative of Milbemycin A3 and A4. The molecular weight of A3 oxime is 541.7, and the molecular weight of A4 oxime is 555.7. In terms of application, milbexime can be used alone or in combination with nitenpyram, lufenuron, spinosad, praziquantel, etc. to form a compound preparation, which can effectively prevent and control heartworms, hookworms, roundworms, whipworms, roundworms and other internal parasites, as well as hair follicles, scabies, lice, fleas and other external parasites. Milbexime acts as an agonist of the GABA (gamma-aminobutyric acid) neurotransmitter in nerve cells and also binds to glutamate-gated Cl– channels in invertebrate nerve and muscle cells. In both cases, it blocks the parasite's nerve signaling, eventually paralyzing the parasite, causing the muscles to lose their ability to contract, stop feeding, and cause the parasite to die.

Global Milbemycin Oxime API market is expected to reach to US$ 209.4 million in 2023, with a positive growth of %, compared with US$ 183.7 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Milbemycin Oxime API industry is evaluated to reach US$ 304 million in 2029. The CAGR will be 6.4% during 2023 to 2029.

Global 3 largest manufacturers of Milbemycin Oxime API are Livzon Pharmaceutical Group Inc, Zhejiang Hisun Pharmaceutical Co., Ltd and Hubei Honch Pharmaceutical Co.,Ltd, which make up over 40%. Among them, Livzon Pharmaceutical Group Inc is the leader with about 22% market share. North America is the largest market, with a share about 48%, followed by Europe and China, with the share about 46% and 2%. In terms of product type, Purity Greater than 98% occupy the largest share of the total market, about 85%. And in terms of product Application, the largest application is Dog, followed by Cat.

Report Covers:
This report presents an overview of global Milbemycin Oxime API market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Milbemycin Oxime API market with multiple angles. Items like regional production, sales, revenue from 2018 to 2029 and manufacturers’ capacity, sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted. 
Manufacturers, Type, Application and Regions Listed in the Report:

Chapter Outline
Chapter 1: Product definition, type and application introduction
Chapter 2: Regional production volume analysis from 2018 to 2029
Chapter 3: Regional revenue and sales volume analysis from 2018 to 2029
Chapter 4: Manufacturers’ sales, revenue and price analysis, including manufacturers’ Milbemycin Oxime API plant distribution, commercial date of Milbemycin Oxime API, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 5: Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 6: Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 7: Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 8: Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 9: Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 10: Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 11: Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 12: Manufacturers’ outline, covering company’s basic information, major business, Milbemycin Oxime API introduction, etc. Milbemycin Oxime API Capacity, Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 13: Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 14: Market opportunities and challenges analysis
Chapter 15: QYResearch’s Conclusions of Milbemycin Oxime API
Chapter 16: Methodology and Data Sources adopted by QYResearch

Industry: Chemical & Material

Published: 2023-07-31

Pages: 77 Pages

Report ld: 1616529

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 4900.00

Multi Users License

USD 7350.00

Corporate Users License